Free Trial
→ Goldman Sachs just told you what to buy (most people missed it) (From Behind the Markets) (Ad)tc pixel Free AIMDW Stock Alerts

Ainos (AIMDW) Competitors

Ainos logo
$0.11 -0.02 (-18.46%)
As of 03:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

AIMDW vs. ALVOW, ARAV, ACABW, BFRIW, and CELUW

Should you buy Ainos stock or one of its competitors? MarketBeat compares Ainos with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ainos include Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

How does Ainos compare to Alvotech?

Ainos (NASDAQ:AIMDW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

In the previous week, Ainos had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Alvotech. Ainos' average media sentiment score of 0.98 beat Alvotech's score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company Overall Sentiment
Ainos Positive
Alvotech Neutral

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Alvotech N/A N/A N/A

Summary

Ainos beats Alvotech on 2 of the 3 factors compared between the two stocks.

How does Ainos compare to Aravive?

Aravive (NASDAQ:ARAV) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

In the previous week, Ainos had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Aravive. Ainos' average media sentiment score of 0.98 beat Aravive's score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
Ainos Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Ainos$18.11KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Ainos N/A N/A N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Ainos beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Ainos compare to Atlantic Coastal Acquisition Corp. II?

Ainos (NASDAQ:AIMDW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

In the previous week, Ainos had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Atlantic Coastal Acquisition Corp. II. Ainos' average media sentiment score of 0.98 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company Overall Sentiment
Ainos Positive
Atlantic Coastal Acquisition Corp. II Neutral

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Summary

Ainos beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

How does Ainos compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

In the previous week, Ainos had 1 more articles in the media than Biofrontera. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Biofrontera. Ainos' average media sentiment score of 0.98 beat Biofrontera's score of 0.00 indicating that Ainos is being referred to more favorably in the news media.

Company Overall Sentiment
Biofrontera Neutral
Ainos Positive

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Summary

Ainos beats Biofrontera on 2 of the 3 factors compared between the two stocks.

How does Ainos compare to Celularity?

Ainos (NASDAQ:AIMDW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Celularity N/A N/A N/A

In the previous week, Ainos had 1 more articles in the media than Celularity. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Celularity. Ainos' average media sentiment score of 0.98 beat Celularity's score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company Overall Sentiment
Ainos Positive
Celularity Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

Summary

Ainos beats Celularity on 2 of the 3 factors compared between the two stocks.

Get Ainos News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIMDW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIMDW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIMDW vs. The Competition

Export
MetricAinosMedical Devices IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.13B$6.44B$12.09B
Dividend YieldN/A2.66%2.67%5.56%
P/E RatioN/A14.5023.8023.78
Price / SalesN/A125.60479.3586.31
Price / CashN/A15.9926.9937.25
Price / BookN/A4.4710.366.80
Net IncomeN/A$144.75M$3.57B$337.51M
7 Day Performance-2.12%-3.01%-1.27%-2.64%
1 Month PerformanceN/A-3.10%3.17%1.90%
1 Year Performance0.47%-0.91%23.59%26.94%

Ainos Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIMDW
Ainos
N/A$0.11
-18.5%		N/A+13.7%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.26
flat		N/A-92.7%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15
BFRIW
Biofrontera
N/A$0.02
flat		N/AN/A$0.00$43.20MN/A70

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AIMDW) was last updated on 6/8/2026 by MarketBeat.com Staff.
From Our Partners
BNZI Breakout Watch: AI Growth Meets Turnaround Setup!
Banzai International (NASDAQ: BNZI) posted full-year 2025 revenue of $12.2 million, up 169% year-over-year, wi...
Huge Alerts | Sponsoredtc pixel
$36 million a day says something big is coming
Institutional capital is flowing into one thesis at a rate of $36 million per day - $25,000 every single minut...
Porter & Company | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...
Brownstone Research | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
In 30 days, you'll wish you'd read this email
A small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...
Behind the Markets | Sponsoredtc pixel
Your name isn't on our protected list yet
I checked our download records for "The Big Beautiful Bubble Report" and didn't see your name. That concern...
American Alternative | Sponsoredtc pixel